Home

Influenzare Verso il basso Monica edoxaban clinical trials Piovoso impedire Prospettiva

Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran,  rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation  in Germany: A real-world cohort study - International Journal of Cardiology
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study - International Journal of Cardiology

Important clinical trials of apixaban, edoxaban, and betrixaban | Download  Scientific Diagram
Important clinical trials of apixaban, edoxaban, and betrixaban | Download Scientific Diagram

Efficacy and safety inputs of edoxaban vs. warfarin, from the... | Download  Table
Efficacy and safety inputs of edoxaban vs. warfarin, from the... | Download Table

Design and rationale of the STroke secondary prevention with catheter  ABLation and EDoxaban clinical trial in patients with non-valvular atrial  fibrillation: The STABLED study - ScienceDirect
Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study - ScienceDirect

Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679  Patients With Atrial Fibrillation and a History of Hypertension in the  ENGAGE AF-TIMI 48 Trial | Hypertension
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial | Hypertension

Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of  atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial -  The Lancet
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet

Efficacy and safety of edoxaban in patients with diabetes mellitus in the  ENGAGE AF-TIMI 48 trial - International Journal of Cardiology
Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial - International Journal of Cardiology

Clinical trial characteristics for patients with atrial fibrillation... |  Download Table
Clinical trial characteristics for patients with atrial fibrillation... | Download Table

Factor Xa inhibitor effective and safe in AF patients with liver disease -  PACE-CME
Factor Xa inhibitor effective and safe in AF patients with liver disease - PACE-CME

Important clinical trials of apixaban, edoxaban, and betrixaban | Download  Scientific Diagram
Important clinical trials of apixaban, edoxaban, and betrixaban | Download Scientific Diagram

Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History  of Liver Disease - ScienceDirect
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease - ScienceDirect

Hokusai-VTE Clinical Trial | SAVAYSA® (edoxaban) | HCP
Hokusai-VTE Clinical Trial | SAVAYSA® (edoxaban) | HCP

Edoxaban: Review of pharmacology and key phase I to III clinical trials. |  Semantic Scholar
Edoxaban: Review of pharmacology and key phase I to III clinical trials. | Semantic Scholar

Study reports low rates of bleeding and VTE after 12 months of edoxaban  treatment
Study reports low rates of bleeding and VTE after 12 months of edoxaban treatment

Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History  of Liver Disease | Journal of the American College of Cardiology
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism |  NEJM
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism | NEJM

Edoxaban May Be Effective Treatment for Atrial Fibrillation After  Transcatheter Aortic Valve Replacement | Mount Sinai - New York
Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York

Edoxaban: Review of pharmacology and key phase I to III clinical trials. |  Semantic Scholar
Edoxaban: Review of pharmacology and key phase I to III clinical trials. | Semantic Scholar

An evidence-based review of edoxaban and its role in stroke prevention | CE
An evidence-based review of edoxaban and its role in stroke prevention | CE

EDOSURE: Worldwide Edoxaban Clinical Research Program
EDOSURE: Worldwide Edoxaban Clinical Research Program

Edoxaban: Review of pharmacology and key phase I to III clinical trials. |  Semantic Scholar
Edoxaban: Review of pharmacology and key phase I to III clinical trials. | Semantic Scholar

An evidence-based review of edoxaban and its role in stroke prevention | CE
An evidence-based review of edoxaban and its role in stroke prevention | CE

Bleeding Events in a Phase II Study of Edoxaban in Patients With Atrial...  | Download Table
Bleeding Events in a Phase II Study of Edoxaban in Patients With Atrial... | Download Table

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM